These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 10423594
1. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy. Sacher HL, Sacher ML, Landau SW, Kersten R, Dooley F, Sacher A, Sacher M, Dietrick K, Ichkhan K. Am J Ther; 1997; 4(2-3):66-72. PubMed ID: 10423594 [Abstract] [Full Text] [Related]
3. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance. Starling MR. Am Heart J; 1994 Jul; 128(1):124-33. PubMed ID: 8017265 [Abstract] [Full Text] [Related]
4. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment. Morisco C, Nappi A, Argenziano L, Sarno D, Fonatana D, Imbriaco M, Nicolai E, Romano M, Rosiello G, Cuocolo A. Mol Aspects Med; 1994 Jul; 15 Suppl():s155-63. PubMed ID: 7752827 [Abstract] [Full Text] [Related]
5. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Soongswang J, Sangtawesin C, Durongpisitkul K, Laohaprasitiporn D, Nana A, Punlee K, Kangkagate C. Pediatr Cardiol; 2005 Jul; 26(4):361-6. PubMed ID: 16374685 [Abstract] [Full Text] [Related]
6. The effect of coenzyme Q10 in patients with congestive heart failure. Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS. Ann Intern Med; 2000 Apr 18; 132(8):636-40. PubMed ID: 10766682 [Abstract] [Full Text] [Related]
7. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, Aroney CN. J Am Coll Cardiol; 1999 May 18; 33(6):1549-52. PubMed ID: 10334422 [Abstract] [Full Text] [Related]
8. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. Soja AM, Mortensen SA. Mol Aspects Med; 1997 May 18; 18 Suppl():S159-68. PubMed ID: 9266518 [Abstract] [Full Text] [Related]
9. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, Röthlisberger C, Skudicky D, Sareli P. J Am Coll Cardiol; 1993 Apr 18; 21(5):1094-100. PubMed ID: 8096228 [Abstract] [Full Text] [Related]
10. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR. Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482 [Abstract] [Full Text] [Related]
11. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy]. Permanetter B, Sebening H, Busch U, Lutilsky L. Z Kardiol; 1990 Aug 01; 79(8):565-72. PubMed ID: 2220013 [Abstract] [Full Text] [Related]
12. Left ventricular volume and ejection fraction response to exercise in chronic congestive heart failure: difference between dilated cardiomyopathy and previous myocardial infarction. Shen WF, Roubin GS, Hirasawa K, Choong CY, Hutton BF, Harris PJ, Fletcher PJ, Kelly DT. Am J Cardiol; 1985 Apr 01; 55(8):1027-31. PubMed ID: 3984862 [Abstract] [Full Text] [Related]
13. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Am J Med; 1990 Mar 01; 88(3):223-9. PubMed ID: 1968710 [Abstract] [Full Text] [Related]
14. Effective and safe therapy with coenzyme Q10 for cardiomyopathy. Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P. Klin Wochenschr; 1988 Jul 01; 66(13):583-90. PubMed ID: 3062263 [Abstract] [Full Text] [Related]
15. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. Lei L, Liu Y. BMC Cardiovasc Disord; 2017 Jul 24; 17(1):196. PubMed ID: 28738783 [Abstract] [Full Text] [Related]
16. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy. Waagstein F, Strömblad O, Andersson B, Böhm M, Darius M, Delius W, Goss F, Osterziel KJ, Sigmund M, Trenkwalder SP, Wahlqvist I. Eur J Heart Fail; 2003 Oct 24; 5(5):679-91. PubMed ID: 14607208 [Abstract] [Full Text] [Related]
17. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment. Sanbe A, Tanonaka K, Niwano Y, Takeo S. J Pharmacol Exp Ther; 1994 Apr 24; 269(1):51-6. PubMed ID: 8169851 [Abstract] [Full Text] [Related]
18. Oral metoprolol therapy in dilated cardiomyopathy: hemodynamic evidence for improved diastolic function accompanying amelioration of symptoms. Sethi KK, Nair M, Arora R, Khalilullah M. Int J Cardiol; 1990 Dec 24; 29(3):317-22. PubMed ID: 2283189 [Abstract] [Full Text] [Related]
19. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Langsjoen PH, Langsjoen PH, Folkers K. Am J Cardiol; 1990 Feb 15; 65(7):521-3. PubMed ID: 2305693 [No Abstract] [Full Text] [Related]
20. [Treatment of chronic cardiac insufficiency with coenzyme Q10, results of meta-analysis in controlled clinical trials]. Soja AM, Mortensen SA. Ugeskr Laeger; 1997 Dec 01; 159(49):7302-8. PubMed ID: 9417729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]